why choose us

First received: January 15, 2024

Clinical Trial: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 2.4 mg/2.4 mg s.c. Once Weekly Versus Tirzepatide 15 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inade

Brief Summary: This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight.CagriSema is a new investigational medicine.Doctors may not yet prescribe CagriSema.CagriSema will be compared to a medicine called tirzepatide that doctors may prescribe in some countries.Participants will get either CagriSema or tirzepatide.Which treatment participant get is decided by chance like flipping a coin.Participant will have an equal chance of receiving either drug.For each participant,…

Read more